| 1 |
34267345 | Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers. | 2022 Apr |
2 |
| 2 |
32705692 | A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment. | 2021 Feb |
2 |
| 3 |
30991038 | Rifampin Induces Expression of P-glycoprotein on the THP1 Cell-Derived Macrophages, Causing Decrease Intramacrophage Concentration of Prothionamide. | 2019 Sep |
2 |
| 4 |
31047967 | Simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 3A/P‑glycoprotein to healthy human using a semi-physiologically based pharmacokinetic model involving both enzyme and transporter turnover. | 2019 Jun 15 |
4 |
| 5 |
30091221 | PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin. | 2018 Oct |
1 |
| 6 |
27118859 | Potential pharmacokinetic effect of rifampicin on enrofloxacin in broilers: Roles of P-glycoprotein and BCRP induction by rifampicin. | 2016 Sep 1 |
3 |
| 7 |
18855943 | Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. | 2009 Mar |
1 |
| 8 |
16026006 | Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques. | 2004 Sep-Oct |
1 |